Company / Operating Income per Share
KalVista Pharmaceuticals, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$4.42
FY2025
5-year range
-$5.41 / -$3.79
FY2021-FY2025
Trend
-16.8%
vs FY2024
Sector context
#164 of 201
Health Care
What the data says
KalVista Pharmaceuticals, Inc.'s operating income per share of $-4.42 is lower than 82% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-5.41 in FY2021 to $-1.56 in FY2018.
Based on SEC 10-K filings.
-4.42 in FY2025.
Declined from $-3.82 to $-4.42 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 201This company -$4.42 Sector average -$3.23
▼
-36.7% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 16.8% year-over-year.
- Ranks #164 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2018.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.42 | -16.8% |
| FY2024 | -$3.79 | +0.8% |
| FY2023 | -$3.82 | +15.9% |
| FY2022 | -$4.54 | +16.1% |
| FY2021 | -$5.41 | -61.5% |
| FY2020 | -$3.35 | -62.1% |
| FY2019 | -$2.07 | -32.3% |
| FY2018 | -$1.56 | +13.8% |
| FY2017 | -$1.81 | +62.3% |
| FY2016 | -$4.81 | +84.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026